Leadingtac Pharmaceutical (shaoxing) Co., Ltd.

This trial tests an experimental oral drug called LT-002-158 in adults with moderate to severe atopic dermatitis, a chronic inflammatory skin condition. The study has two parts: first, a small group receives the drug to check safety and tolerability; second, a larger group receiv…

This trial tests an experimental oral drug called LT-002-158 in adults with moderate-to-severe hidradenitis suppurativa, a chronic skin condition causing painful abscesses and nodules. The study first checks the drug's safety and tolerability, then compares its effectiveness agai…